TrialThe oncologist2021

Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer.

Yuan Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.